Form D · Other Technology
Revella Health Inc.
Birmingham, AL · CIK 0002051383
Offering snapshot reported Jan 16, 2025 · SEC filing
- Reported sold
- $538K Offering amount: $700K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 16, 2025 | Initial | $538,499 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535424
Source: Form D, filed Jan 16, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Yeboah | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1 Perimeter Park S Suite 100 N
Birmingham, AL, 35243
Birmingham, AL, 35243